Purchase Order 75D30123P16406
Award Date
7/25/23
Potential Completion Date
7/25/24
Potential Value
$134K
Federal Agency
CDC Pittsburgh
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $205,000 purchase order to Qiagen, LLC for their EZ! ADVANCED XL SYSTEM. Qiagen, a subsidiary of Qiagen N.V., will provide its sample preparation and nucleic acid extraction platform to support CDC programs through a one-month period of performance ending in late August 2023. The firm fixed price contract calls for Qiagen to deliver its proprietary system to help CDC process samples...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $32,000 purchase order to Qiagen, LLC for a QIAGEN ROBOT. Qiagen, LLC is a division of Qiagen N.V., which will serve as the prime contractor to deliver the robotic system to the CDC location in Germantown, Maryland between September 12-29, 2023. The contract has a firm fixed price and will support the CDC's efforts to modernize its laboratory equipment and processes. No major...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a firm fixed price purchase order valued at approximately $8,721 to Qiagen, LLC for the delivery of TISSUELYSER LT laboratory equipment. As a division of Qiagen N.V., Qiagen will perform as the prime contractor under the contract to provide the requested products and services. The place of performance will be Qiagen's Germantown, Maryland facility. The period of performance spans from...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
This federal contract award is for $116,467.47 to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The contract is for "CORONAVIRUS LAB SUPPLIES" and was awarded on February 28, 2020 by the Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh. The contract is a Firm Fixed Price Purchase Order with a completion date of March 4, 2020. Qiagen is a foreign-owned, for-profit manufacturer that...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $133,979.07 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the provision of laboratory equipment and furniture, with a completion date of November 15, 2023. Qiagen is a manufacturer of products and provider of services to support federal agencies' biomedical research, public health, law enforcement, and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...
Qiagen, LLC was awarded a purchase order for $66,592.30 by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to provide EZ1 & 2 DNA Tissue Kits, Buffer AL, and Qiagen Proteinase K. No set-aside designation was applied to this contract. Performance will take place in Germantown, Maryland through August 31, 2023. Qiagen, a division of Qiagen N.V., will deliver the requested DNA extraction products to support the Centers for Disease Control and...
The Centers for Disease Control and Prevention (CDC) awarded a $50,613 purchase order contract to Qiagen, LLC to provide products and services in support of the agency's public health programs. As a subsidiary of Qiagen N.V., Qiagen will deliver items from its product catalog to the CDC location in Germantown, Maryland under a firm fixed price arrangement. No additional details were provided on the scope of work. The award draws from the CDC's annual appropriations and advances the agency's...
Qiagen, LLC has been awarded a $50,809.30 firm fixed price purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention located in Pittsburgh, Pennsylvania. The award is for the delivery of QIACUBE HT/QIAXTRACTOR platforms and reagents to support the agency's biomedical research and public health programs. No set-aside designation was applied to this procurement. Performance will take place in Germantown, Maryland by Qiagen, a division of Qiagen...